BeStock  

Mesa Laboratories MLAB

US equityMarket cap rank #3367Scientific & Technical Instruments
$127.93 −$5.48 (-4.11%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $127.93 0.00%
Open$131.62
Prev close$133.41
Day range$126.73 – $134.00
Volume76.0K
Market cap$719.03M
P/E (TTM)110.3
Dividend yield0.50%

Earnings

Average move on report day±7.0%last 16 reports
Closed higher8 of 1650% of the time
Best reaction+11.0%
Worst reaction-24.9%

Stock move on the day after each report

-2.0%2023/Q4+5.2%2024/Q1-1.4%2024/Q2+5.6%2024/Q3-13.3%2024/Q4+2.5%2025/Q3-24.9%2026/Q1+1.5%2026/Q2+8.7%2026/Q3-14.5%2026/Q4-1.0%2027/Q1+7.1%2027/Q2
QuarterReport dateTimingImplied moveActual moveVersus implied
2027/Q29 Nov 2026After Market–+7.11%–
2027/Q110 Aug 2026None–-1.00%–
2026/Q427 May 2026Pre Market–-14.48%–
2026/Q33 Feb 2026Pre Market–+8.73%–
2026/Q26 Nov 2025After Market–+1.52%–
2026/Q15 Aug 2025Pre Market–-24.92%–
2025/Q34 Feb 2025Pre Market–+2.49%–
2024/Q431 May 2024Pre Market–-13.28%–
2024/Q35 Feb 2024Pre Market–+5.64%–
2024/Q26 Nov 2023Pre Market–-1.41%–
2024/Q13 Aug 2023Pre Market–+5.23%–
2023/Q425 May 2023Pre Market–-1.97%–
2023/Q36 Feb 2023Pre Market–-9.08%–
2019/Q34 Feb 2019Pre Market–+1.42%–
2018/Q35 Feb 2018After Market–-3.32%–
2016/Q42 Jun 2016None–+11.01%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2027/Q2

By business line

  • Sterilization and Disinfection Control$25.34M 40.7%
  • Calibration Solutions$14.05M 22.5%
  • Biopharmaceutical Development$12.78M 20.5%
  • Clinical Genomics$10.17M 16.3%

Latest reported quarter: Q2, ended Sep 2026

Revenue$62.34M+2.6% YoY
Operating profit$8.39M+77.6% YoY
Net profit$4.34M+75.3% YoY
Diluted EPS$0.75+66.7% YoY
Free cash flow$3.71M-48.0% YoY
Operating cash flow$4.10M

Revenue, last 8 quarters

$62.8MDec '24$62.1MMar '25$59.5MJun '25$60.7MSep '25$65.1MDec '25$63.7MMar '26$60.1MJun '26$62.3MSep '26

Net profit, last 8 quarters

$-1.7MDec '24$-7.1MMar '25$4.7MJun '25$2.5MSep '25$3.6MDec '25$-4.1MMar '26$2.8MJun '26$4.3MSep '26

Profitability & balance sheet

Gross margin64.8%
Operating margin10.4%
Net margin2.7%
Return on equity3.6%
Return on assets1.6%
Return on invested capital3.7%
Current ratio1.90
Liabilities / assets52.3%
Cash & investments$22.31M
Total debt$131.51M
Net cash (debt)-$109.19M
Free cash flow / sales19.7%

Discussion

No comments yet — be the first to weigh in on MLAB.

Sign in to join the discussion.

Scroll to Top